First and Last Name/s of Presenters

Teresa PacelliFollow

Mentor/s

Dr. Mark Jareb and Dr. Barbara Pierce

Location

Panel C: UC 107

Start Day/Time

4-21-2017 2:00 PM

End Day/Time

4-21-2017 3:15 PM

Abstract

There are many different opposing studies about respiratory distress and how it affects premature infants as well as adults. The main focus is on how infants can be treated of acute respiratory distress syndrome or ARDS, which is more common when they are born prematurely. This analytical review is designed to capture all the past and present data in order to present both sides of controversy in the different treatments to treat respiratory distress in premature infants. The data finds that inhaled nitric oxide (iNO) is one of the main treatments for respiratory distress and has had a lot of controversy over the years. Most of the research points to the usefulness of iNO in different doses, although it is controversial as to the right dose amount. There are also a few other treatment possibilities that still need further research. iNO is useful as a treatment, and to hold as a temporary treatment before other treatments can be administered. However, it still has different risks involved especially when dealing with infants.

College

College of Arts and Sciences

College and Major available

Biology

Keywords

Premature infants

Document Type

Poster

Creative Commons License

Creative Commons Attribution-Noncommercial-Share Alike 3.0 License
This work is licensed under a Creative Commons Attribution-Noncommercial-Share Alike 3.0 License.

Share

COinS
 
Apr 21st, 2:00 PM Apr 21st, 3:15 PM

Treatment for Respiratory Distress in Premature Infants

Panel C: UC 107

There are many different opposing studies about respiratory distress and how it affects premature infants as well as adults. The main focus is on how infants can be treated of acute respiratory distress syndrome or ARDS, which is more common when they are born prematurely. This analytical review is designed to capture all the past and present data in order to present both sides of controversy in the different treatments to treat respiratory distress in premature infants. The data finds that inhaled nitric oxide (iNO) is one of the main treatments for respiratory distress and has had a lot of controversy over the years. Most of the research points to the usefulness of iNO in different doses, although it is controversial as to the right dose amount. There are also a few other treatment possibilities that still need further research. iNO is useful as a treatment, and to hold as a temporary treatment before other treatments can be administered. However, it still has different risks involved especially when dealing with infants.

 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.